Lasa Supergenerics to set up brownfield expansion at Chiplun unitIllustrative image – not actual.
Lasa Supergenerics, a manufacturer of veterinary and human APIs in India through its catalyst chemistry expertise and fully backward integrated unit, has added another product -- Oxyclozanide to its portfolio of products.
 
Oxyclozanide is an anthelmintic. It is used in the treatment and control of fascioliasis, a tropical worm infection in ruminants mainly domestic animals such as cattle (especially buffalos in farm), sheep and goats. 
 
For this, the company is setting up capacity in a brownfield expansion at its Chiplun unit in Maharashtra. The total capacity would be 250 tonne. 
 
The company is committed to funding the required capex through internal accruals. The production would start from August 2021. 
 
The company already has export approvals for several regions. Oxyclozanide would also be exported to these regions.
← All latest storiesBack to top →